These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8461029)

  • 1. Characterization of recombinant human serotonin 5HT1A receptors expressed in Chinese hamster ovary cells. [3H]spiperone discriminates between the G-protein-coupled and -uncoupled forms.
    Sundaram H; Newman-Tancredi A; Strange PG
    Biochem Pharmacol; 1993 Mar; 45(5):1003-9. PubMed ID: 8461029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of recombinant serotonin 5-HT1A receptors expressed in Chinese hamster ovary cells: the agonist [3H]lisuride labels free receptor and receptor coupled to G protein.
    Sundaram H; Turner JD; Strange PG
    J Neurochem; 1995 Nov; 65(5):1909-16. PubMed ID: 7595473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
    Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterisation of the 5-HT1A serotonin receptor using the agonist [3H]8-OH-DPAT, and the antagonist [3H]spiperone.
    Sundaram H; Newman-Tancredi A; Strange PG
    Biochem Soc Trans; 1992 May; 20(2):145S. PubMed ID: 1397539
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X; Ennis C; Minchin MC
    Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
    Jerning E; Rosqvist S; Mohell N
    J Recept Signal Transduct Res; 2002; 22(1-4):483-95. PubMed ID: 12503636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT(1A) receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems.
    Watson J; Collin L; Ho M; Riley G; Scott C; Selkirk JV; Price GW
    Br J Pharmacol; 2000 Jul; 130(5):1108-14. PubMed ID: 10882396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A; Verrièle L; Millan MJ
    Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level stable expression of recombinant 5-HT1A 5-hydroxytryptamine receptors in Chinese hamster ovary cells.
    Newman-Tancredi A; Wootton R; Strange PG
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):933-8. PubMed ID: 1386736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
    Schlegel JR; Peroutka SJ
    Biochem Pharmacol; 1986 Jun; 35(12):1943-9. PubMed ID: 3013203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry.
    Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Millan MJ
    Neuropharmacology; 1997; 36(4-5):451-9. PubMed ID: 9225269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
    Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of [3H]5-hydroxytryptamine and [3H]spiperone binding sites in clathrin-coated vesicles from bovine brain.
    Moroi K; Ozaki N; Kadota T; Kadota K
    Brain Res; 1998 Jun; 794(2):291-8. PubMed ID: 9622654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.
    Herrick-Davis K; Titeler M
    J Neurochem; 1988 Feb; 50(2):528-33. PubMed ID: 2961850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
    Yokota N; Yamawaki S; Hayakawa H; Yoshida R; Sarai K
    Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist.
    Jerning E; Svantesson GT; Mohell N
    Eur J Pharmacol; 1998 Nov; 360(2-3):219-25. PubMed ID: 9851589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
    Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
    J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues.
    Harrington MA; Peroutka SJ
    J Neurochem; 1990 Jan; 54(1):294-9. PubMed ID: 2136705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency of 5-hydroxytryptamine1a agonists to inhibit adenylyl cyclase activity is a function of affinity for the "low-affinity" state of [3H]8-hydroxy-N,N-dipropylaminotetralin ([3H]8-OH-DPAT) binding.
    Chamberlain J; Offord SJ; Wolfe BB; Tyau LS; Wang HL; Frazer A
    J Pharmacol Exp Ther; 1993 Aug; 266(2):618-25. PubMed ID: 8355195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.